Capital Allocation

Unisync Corp. announces its first-ever share repurchase program, leveraging strong defense contracts to buy back up to 7.1% of its public float.

While Wall Street frets over regional bank stability, an Ohio community lender leverages its Midwest roots to mark 32 years of dividend growth.

ACRES Commercial Realty's $5M buyback is more than a financial maneuver; it’s a bid to rebuild public trust amid a shifting commercial real estate landscape.

As AI infrastructure costs strain law firms and CFOs turn disputes into balance-sheet assets, legal finance is quietly reshaping corporate strategy.

Arco Vara executes a masterclass in regional consolidation, utilizing a self-financed management buyout to exit Bulgaria and fund Tallinn megaprojects.

Fairfax Financial is renewing its massive share repurchase program. Behind the regulatory filing lies a masterclass in capital allocation, liquidity management, and balance sheet optimization.

Bimergen Energy aims to erase a 50% equity overhang to woo institutional partners, but a pending $100M shelf filing reveals a deeper strategic paradox.

Institutional investors and GCC healthcare giants are treating the global women's health gap not as a niche, but as a $1 trillion macroeconomic catalyst.

First Merchants' $100M subordinated debt offering highlights a savvy capital optimization strategy, swapping Tier 2 debt for equity to fund share repurchases.

Veralto’s $0.13 dividend might seem modest, but behind the yield lies a masterclass in capital allocation, high-margin economics, and global resource management.

Record revenues and a £63.5M stadium land grab signal ambition, but currency swings and mounting debt prove INEOS still faces a grueling financial rebuild.

AAPI-owned funds consistently outperform peers across every asset class, yet manage just 0.49% of AUM. Why are allocators leaving $225 billion on the table?

A 50-basis-point margin cut on a $1.95 billion debt stack reveals a masterclass in capital structure optimization and post-merger integration.

Activist investor Corvex Management is escalating its battle with Whitbread, pushing to install James Gemmel on the board to rethink the hotelier's real estate.

Titan International’s $285 million divestiture of ITM isn’t just a balance sheet cleanup—it’s a calculated pivot toward defense contracts and domestic manufacturing supremacy.

Surging oil volumes met a $1.4 million capital expenditure spike, exposing the structural realities of energy royalty trusts in a high-price environment.

As regulatory headwinds clear and a new CEO takes the helm, Omega Healthcare Investors is shifting from passive landlord to active global operator.

Nucor's latest dividend declaration marks 53 years of payouts, signaling more than just financial health—it's a barometer for American infrastructure.

Amerant Bancorp's latest 7% senior note issuance reveals the steep but necessary cost of capital for mid-sized banks chasing aggressive regional growth.

Siguler Guff's record $3 billion close highlights a massive structural shift as investors abandon over-leveraged mega-caps for founder-owned lower middle-market firms.